Streetbeat News

Analyst Ratings

BKNG

A large bearish position on Booking Holdings (NASDAQ:BKNG) has been spotted, with 69% of big-money traders showing bearish sentiment. Whales have been targeting a price range of $2230 to $3040 for BKNG over the last 3 months.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 2:17 pm

FOXA

Citigroup analyst Jason Bazinet maintains a Neutral rating on Fox (NASDAQ:FOXA) and lowers the price target from $40 to $35.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 2:17 pm

CFRX

Zacks Small-Cap Research has issued a note on ContraFect, assigning a $7 valuation to the company's stock.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 2:15 pm

RGA

Citigroup analyst Michael Ward maintains a Buy rating on Reinsurance Gr (NYSE:RGA) and raises the price target from $158 to $170.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 2:14 pm

RPD

Citigroup analyst Fatima Boolani maintains a Neutral rating on Rapid7 (NASDAQ:RPD) and lowers the price target from $59 to $50.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 2:13 pm

TTWO

Citigroup analyst Jason Bazinet maintains a Neutral rating on Take-Two Interactive (NASDAQ:TTWO) and lowers the price target from $140 to $121.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 2:12 pm

FIVN

Analysts have provided ratings for Five9 (NASDAQ:FIVN) within the last quarter, with 6 bullish, 3 somewhat bullish, and 2 indifferent ratings. The average price target is $85.91, implying an upside from the current price of $63.15.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 2:06 pm

CHRS

Over the past 3 months, 6 analysts have published their opinion on Coherus BioSciences (NASDAQ:CHRS) stock, with 4 bullish and 2 somewhat bullish ratings. The company has an average 12-month price target of $17.67, down 15.86% from the previous average of $21.00.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 2:05 pm

BPMC

Over the past 3 months, 18 analysts have published their opinions on Blueprint Medicines (NASDAQ:BPMC) stock, with an average 12-month price target of $74.06. The average price target has increased by 25.76% over the past month.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 2:04 pm

TSLA

A recent analysis of Tesla's (NASDAQ:TSLA) unusual options activity reveals that 52% of investors have taken a bearish stance, with whales targeting a price range of $175 to $330 over the last 3 months. Analysts from Wedbush, Jefferies, and Piper Sandler have given price targets of $215, $185, and $280, respectively.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 2:03 pm